Eurobio Scientific
EurobioPlex
EurobioPlex Coxiella burnetii
The EurobioPlex Coxiella burnetii test uses real time polymerase chain reaction (PCR) amplification and is designed for the qualitative detection of Coxiella burnetii from a DNA nucleic acids extract. This test is indicated to confirm a diagnosis of presumption of infection in patients or complete a proven or indeterminate diagnosis.
- Coxiella burnetii / CI-PCR
- CE-IVD
- Packaging: 24, 48, 96 tests
- Qualitative
- Serum, Culture, Blood, Cardiac biopsy, Pharyngeal biopsy, Bone biopsy, Puncture fluid, Lymph node biospy, Biopsy of aneurysmal cell
Discover our marketing tools! You have questions or want more informations?
- REF : EBX-017
- Pathogens : Coxiella burnetii / CI-PCR
- Shipment : Dry ice
- Storage at -20 °C
- EurobioPlex Thermocycleur : CFX96™Real Time PCR detection system (Bio-Rad), LightCycler® 480 Instrument II (Roche), Applied Biosystems® 7500 Real Time PCR Systems (Applied Biosystems), T-COR8™-IVD (Tetracore Inc)
- EurobioPlex Extractor : DNA extraction Suitable for Respiratory specimens
| Coxiella burnetii | |
| Analytical Sensitivity on CFX96 in copies /µl | 10 |
| Clinical sensitivity | > 99% |
| Clinical specificity | > 99% |
You may also like
Related products
- EurobioPlex
EBX GI Helminths
EurobioPlex GI Helminths (EBX-083) is a multiplex real-time PCR assay for the qualitative detection of 10 intestinal helminths
- Bacteriology
EurobioPlex Strepto B
The EurobioPlex Strepto B is a bacterial DNA nucleic acid amplification test of S. agalactiae as well as of a PCR Inhibition Control, which uses real-time PCR amplification. The test is performed directly on a vaginal swab.
- EurobioPlex
EurobioPlex DermaScreen
The EurobioPlex DermaScreen (EBX-073) is a qualitative real-time multiplex PCR
- EurobioPlex
EurobioPlex HEV
Eurobioplex HEV is a real-time polymerase chain reaction (PCR) assay designed for the qualitative and quantitative detection of the presence or absence of this virus in an RNA nucleic acid extract.
Our Products & Services
For the field of transplantation, the group produces reagents and software for transplant matching and chimerism monitoring and culture media for cornea graft transplants.
Eurobio Scientific manufactures prognostic genetics tests for breast cancer and prostatic cancer.
The group develops and markets genetic molecular tests to detect a wide variety of illnesses, including detecting infectious diseases, fertility testing or assaying dermatological conditions.
To support the research and development field, Eurobio Scientific has a broad portfolio in Life Sciences products including cell culture media and quality controls.

